Data processing: financial – business practice – management – or co – Automated electrical financial or business practice or... – Health care management
Reexamination Certificate
2011-03-29
2011-03-29
O'Connor, Gerald J. (Department: 3686)
Data processing: financial, business practice, management, or co
Automated electrical financial or business practice or...
Health care management
C707S793000
Reexamination Certificate
active
07917374
ABSTRACT:
Method and system for identifying safety concerns regarding a new drug. In one example, a database of healthcare claims is utilized and the method may include identifying from the database a first group of patients that have received the drug; extracting one or more medical events that the first group of patients have experienced; identifying a second group of patients that have received a comparator drug; extracting one or more medical events that the second group of patients have experienced; and comparing the one or more medical events of the first group to the one or more medical events of the second group to determine one or more common occurrences therebetween. The method may also include computing a probability value for each of the one or more common occurrences. In this way, embodiments of the present invention may be used to identify and quantify the probability that certain medical events will occur to patients taking the new drug.
REFERENCES:
patent: 5845255 (1998-12-01), Mayaud
patent: 6219674 (2001-04-01), Classen
patent: 6529892 (2003-03-01), Lambert
patent: 6584472 (2003-06-01), Classen
patent: 7461006 (2008-12-01), Gogolak
patent: 2002/0083080 (2002-06-01), Classen
patent: 2002/0183965 (2002-12-01), Gogolak
patent: 2003/0046110 (2003-03-01), Gogolak
patent: 2005/0079511 (2005-04-01), Mandema et al.
patent: 2006/0111847 (2006-05-01), Pearson et al.
patent: 2006/0195418 (2006-08-01), Classen
patent: 2007/0033075 (2007-02-01), Hoffman et al.
patent: 2310060 (1997-08-01), None
patent: WO 02/088901 (2002-11-01), None
patent: WO 02/089015 (2002-11-01), None
patent: WO 2005/031509 (2005-04-01), None
Walker, Alexander M., “Patterns of Interchange in the Dispensing of Non-Steroidal Anti-Inflammatory Drugs”, J. Clin. Epidemiol. vol. 45, No. 2, pp. 187-195, 1992.
Walker, Alexander M., “Pattern Recognition in Health Insurance Claims Databases”, Parmacoepidemiology and Drug Safety, 2001; 10; 393-397.
Walker, Alexander M., “Postmarketing Follow Up”, JAMA, Nov. 23, 1979—vol. 242, No. 21.
Graham, David J., et al., “Incidence of Hospitalized Rhabdomyolosis in Patients Treated with Lipid-Lowering Drugs” (JAMA, Dec. 1, 2004, vol. 292, No. 21, pp. 2585-2590).
Geraud, G., et al., “Tolerability and safety of frovatripan with short-and long-term use of treatment of migraine and in comparison with sumatripan” ( Headache, Apr. 2002, 42 Suppl. 2:S93-9).
Layton, Deborah, et al. “Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding?” (Eur. J. Clin. Pharmacol. (2001) 57: 167-176).
Smalley, Walter., et al. “Contraindicated Use of Cisapride—Impact of Food and Drug Administration Regulatory Action”, (JAMA, Dec. 20, 2000, vol. 284, No. 23, pp. 3036-3039).
Enger, Cheryl, et al. “Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States” (Pharmacoepidemiology and Drug Safety 2002; 11: 477-486.
Dorsey & Whitney LLP
Ingenix Inc.
Nguyen Hiep V.
O'Connor Gerald J.
LandOfFree
System and method for early identification of safety... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with System and method for early identification of safety..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and System and method for early identification of safety... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2660953